Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Bioimpedance Spectroscopy May Better Identify Lymphedema Progression

Key clinical point: Bioimpedance spectroscopy may better identify lymphedema progression in women at risk for breast cancer–related lymphedema over the traditionally used method of monitoring arm circumference with a tape measure.

Major finding: In the bioimpedance spectroscopy group, there was a 10% absolute reduction and 67% relative reduction in lymphedema progression.

Study details: Interim analysis from the PREVENT trial.

Disclosures: The study was funded by ImpediMed. Dr. Ridner reports being the principal investigator for ImpediMed and Tactile Medical through work agreements contracted between the companies and her institution.

Citation:

REPORTING FROM ASBS 2019